Subject: SVY
50 Key Biotech Companies Shaping the Biotherapeutics Market: Report
ROCKVILLE, Md., Dec. 18, 2017 /PRNewswire/ -- There are 50 key biotechnology companies that are shaping the biotherapeutics market in 2017 and beyond, according to Kalorama Information. The biotherapeutics sector, composed of biopharmaceuticals and biotechnology, is the fastest growing sector in the pharmaceutical industry. The companies discussed in the healthcare market research firm's report, 50 Key Biopharmaceutical and Biotechnology Companies, were chosen for a variety of reasons, including sales of marketed biopharmaceutical products, innovation in biotherapeutics, and unique additions to the market, either marketed products or products in development.
"Since 1995, biotech patents have increased 25% every year and the clinical pipeline is full of new biologics," said Bruce Carlson, Publisher of Kalorama Information. "These important companies either produce biotherapeutics or have a supporting role in providing essential equipment. New developments in immunotherapies, gene and cell therapies and antibody drug conjugates will continue to impact growth."
The 50 key biopharmaceutical and biotechnology companies include large traditional pharmaceutical powerhouses such as Pfizer, Novartis, Roche, Merck, GlaxoSmithKline, Bristol-Myers Squibb, Bayer, and others; but it also includes smaller niche companies such as Genmab and Seattle Genetics. In addition, it includes leading biopharmaceutical firms such as Amgen and Biogen, and leading biotechnology companies such as Qiagen, Alexion, Agilent, and Waters.
50 Key Biopharmaceutical and Biotechnology Companies examines such various firms in-depth. The companies profiled are:
- AbbVie
- Agilent Technologies Inc.
- Alexion Pharmaceuticals Inc
- Allergan plc
- Ambry Genetics
- Amgen, Inc
- AstraZeneca plc
- Bayer AG
- Berry Genomics Co Ltd.
- Biogen
- BioMarin Pharmaceutical Inc
- Bristol Myers Squibb
- Celgene
- CRISPR Therapeutics AG
- CSL Behring
- Dr. Reddy's Laboratories Limited
- Eli Lilly & Co
- Enzo Biochem, Inc
- Evotec AG
- Exelixis
- Genmab
- Gilead Sciences
- GlaxoSmithKline
- Grifols International S.A.
- Guardant Health
- Illumina
- Incyte Corporation
- Johnson & Johnson
- Merck & Co, Inc.
- Mylan
- Myriad Genetics
- Novartis International AG
- Novo Nordisk A/S
- Organogenesis
- Oxford Nanopore Technologies
- Perkin Elmer, Inc
- Pfizer
- Precision BioSciences Inc
- QIAGEN N.V.
- Regeneron Pharmaceuticals
- Roche Ltd.
- Sanofi
- Seattle Genetics, Inc
- Shire
- Takeda
- Teva Pharmaceutical Industries, Ltd.
- Thermo Fisher Scientific, Inc
- UCB S.A.
- United Therapeutics Corporation
- Waters Corporation
Kalorama's report presents detailed information about each company discussed, including: a corporate summary, selected biopharmaceutical products, biopharmaceuticals in development, selected corporate developments, company financials, and regional revenue breakdown by percentage. 50 Key Biopharmaceutical and Biotechnology Companies can be found at: https://www.kaloramainformation.com/Key-Biopharmaceutical-Biotechnology-Companies-11324862/.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website.
Press Contact:
Bruce Carlson
212 807 2262
[email protected]
SOURCE Kalorama Information
These press releases may also interest you
|
News published on and distributed by:
